Stocks
CVS Health Corporation Financial Statements (CVS) |
||||||||||
| CVS Health Corporationsmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 03.05.2023 | 02.08.2023 | 01.11.2023 | 07.02.2024 | 01.05.2024 | 01.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 85 278 | 88 921 | 89 764 | 93 813 | 88 437 | 360 935 | |||
| Operating Income, bln rub | 3 446 | 3 234 | 3 690 | 3 373 | 2 271 | 12 568 | ||||
| EBITDA, bln rub | ? | 4 818 | 4 856 | 3 690 | 4 529 | 3 434 | 16 509 | |||
| Net profit, bln rub | ? | 2 136 | 1 901 | 2 261 | 2 046 | 1 113 | 7 321 | |||
| OCF, bln rub | ? | 7 438 | 5 908 | 2 716 | -2 636 | 4 903 | 10 891 | |||
| CAPEX, bln rub | ? | 984.0 | 591.0 | 545.0 | 911.0 | 705.0 | 2 752 | |||
| FCF, bln rub | ? | 6 454 | 5 317 | 2 171 | -3 547 | 4 198 | 8 139 | |||
| Dividend payout, bln rub | 779.0 | 795.0 | 779.0 | 779.0 | 840.0 | 3 193 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 36.5% | 41.8% | 34.5% | 38.1% | 75.5% | 43.6% | ||||
| OPEX, bln rub | 9 580 | 9 873 | 9 876 | 10 503 | 10 290 | 40 542 | ||||
| Cost of production, bln rub | 71 903 | 75 318 | 140 762 | 79 937 | 75 876 | 371 893 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 589.0 | 686.0 | 693.0 | 690.0 | 716.0 | 2 785 | ||||
| Assets, bln rub | 239 330 | 250 071 | 251 306 | 249 728 | 249 743 | 249 743 | ||||
| Net Assets, bln rub | ? | 71 382 | 72 726 | 74 337 | 76 461 | 73 968 | 73 968 | |||
| Debt, bln rub | 76 478 | 82 136 | 80 096 | 79 385 | 81 792 | 81 792 | ||||
| Cash, bln rub | 17 720 | 16 887 | 16 188 | 11 455 | 13 089 | 13 089 | ||||
| Net debt, bln rub | 58 758 | 65 249 | 63 908 | 67 930 | 68 703 | 68 703 | ||||
| Ordinary share price, rub | 74.3 | 69.1 | 69.8 | 79.0 | 79.8 | 69.7 | ||||
| Number of ordinary shares, mln | 1 283 | 1 283 | 1 287 | 1 288 | 1 260 | 1 260 | ||||
| Market cap, bln rub | 95 340 | 88 694 | 89 858 | 101 700 | 100 498 | 87 784 | ||||
| EV, bln rub | ? | 154 098 | 153 943 | 153 766 | 169 630 | 169 201 | 156 487 | |||
| Book value, bln rub | -39 043 | -48 652 | -46 548 | -44 045 | -46 074 | -46 074 | ||||
| EPS, rub | ? | 1.66 | 1.48 | 1.76 | 1.59 | 0.88 | 5.81 | |||
| FCF/share, rub | 5.03 | 4.14 | 1.69 | -2.75 | 3.33 | 6.46 | ||||
| BV/share, rub | -30.4 | -37.9 | -36.2 | -34.2 | -36.6 | -36.6 | ||||
| EBITDA margin, % | ? | 5.65% | 5.46% | 4.11% | 4.83% | 3.88% | 4.57% | |||
| Net margin, % | ? | 2.50% | 2.14% | 2.52% | 2.18% | 1.26% | 2.03% | |||
| FCF yield, % | ? | 18.2% | 19.9% | 12.6% | 10.2% | 8.10% | 9.27% | |||
| ROE, % | ? | 5.58% | 4.03% | 11.6% | 10.9% | 9.90% | 9.90% | |||
| ROA, % | ? | 1.66% | 1.17% | 3.42% | 3.34% | 2.93% | 2.93% | |||
| P/E | ? | 24.0 | 30.3 | 10.4 | 12.2 | 13.7 | 12.0 | |||
| P/FCF | 5.48 | 5.02 | 7.95 | 9.78 | 12.3 | 10.8 | ||||
| P/S | ? | 0.29 | 0.26 | 0.26 | 0.28 | 0.28 | 0.24 | |||
| P/BV | ? | -2.44 | -1.82 | -1.93 | -2.31 | -2.18 | -1.91 | |||
| EV/EBITDA | ? | 8.04 | 8.41 | 8.97 | 9.48 | 10.2 | 9.48 | |||
| Debt/EBITDA | 3.07 | 3.56 | 3.73 | 3.80 | 4.16 | 4.16 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 1.15% | 0.66% | 0.61% | 0.97% | 0.80% | 0.76% | ||||
| CVS Health Corporation shareholders | ||||||||||
